239 related articles for article (PubMed ID: 29625594)
1. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.
Yoshida K; Fujiwara Y; Goto Y; Kohno T; Yoshida A; Tsuta K; Ohe Y
BMC Cancer; 2018 Apr; 18(1):398. PubMed ID: 29625594
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
4. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
Agaimy A
Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
Kohashi K; Oda Y
Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous SMARCB1-deficient carcinoma.
Hui Y; Cotzia P; Rana S; Kezlarian BE; Lin O; Hollmann TJ; Dogan S
J Cutan Pathol; 2021 Aug; 48(8):1051-1060. PubMed ID: 33625734
[TBL] [Abstract][Full Text] [Related]
7. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
[TBL] [Abstract][Full Text] [Related]
11. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
12. Head and neck INI1-deficient carcinoma without primary: a case report.
Dubray-Vautrin A; Ghanem W; Bozec L; Gonin J; Choussy O
J Med Case Rep; 2023 Nov; 17(1):479. PubMed ID: 37974295
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature.
Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D
World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402
[TBL] [Abstract][Full Text] [Related]
14. INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland.
Srinivasan A; Tuluc M; Jordan AJ; Curry JM; Bilyk JR
Ophthalmic Plast Reconstr Surg; 2019; 35(2):e41-e43. PubMed ID: 30856630
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
16. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H
Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580
[TBL] [Abstract][Full Text] [Related]
17. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
[TBL] [Abstract][Full Text] [Related]
20. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
